[Federal Register: October 30, 2002 (Volume 67, Number 210)]
[Notices]
[Page 66162-66163]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr30oc02-87]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Vaccines and Related Biological Products Advisory Committee;
Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). At least one
portion of the meeting will be closed to the public.
Name of Committee: Vaccines and Related Biological Products
Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on November 18, 2002, from
1 p.m. to 3:30 p.m.
Location: Food and Drug Administration, Bldg 29B, conference room
C, 29 Lincoln Dr., Bethesda, MD.
[[Page 66163]]
This meeting will be held by a telephone conference call. The public is
welcome to attend the open portion of the meeting. A speaker phone will
be provided at the specified location.
Contact Person: Jody G. Sachs or Denise H. Royster, Center for
Biologics Evaluation and Research (HFM-71), Food and Drug
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301 827-0314,
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12391. Please call the
Information Line for up-to-date information on this meeting.
Agenda: The committee will review and discuss the intramural
research programs of the Laboratory of Enteric and Sexually Transmitted
Diseases, Office of Vaccines Research and Review.
Procedure: On November 18, 2002, from 1 p.m. to 3 p.m., the meeting
is open to the public. Interested persons may present data,
information, or views, orally or in writing, on issues pending before
the committee. Written submissions may be made to the contact person by
November 1, 2002. Oral presentations from the public will be scheduled
between approximately 2 p.m. and 3 p.m. Time allotted for each
presentation may be limited. Those desiring to make formal oral
presentations should notify the contact person before November 1, 2002,
and submit a brief statement of the general nature of the evidence or
arguments they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation.
Closed Committee Deliberations: On November 18, 2002, from 3 p.m.
to 3:30 p.m., the meeting will be closed to permit discussion where
disclosure would constitute a clearly unwarranted invasion of personal
privacy (5 U.S.C. 552b(c)(6)).
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Jody G. Sachs or
Denise H. Royster at least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: October 23, 2002.
LaJuana D. Caldwell,
Acting Senior Associate Commissioner for External Relations.
[FR Doc. 02-27574 Filed 10-29-02; 8:45 am]
BILLING CODE 4160-01-S